Oculis
OCS
8.50
-0.22
-2.52%
Oculis
US · OCS
#3716 by market cap
8.50
-0.22
-2.52%
Live - 5344 symbols - heartbeat 567s ago
· 2026-10-08 08:34
Pre-market
8.70
+2.35%
After-hours
8.50
0.00%
Overnight
8.89
+4.59%
- Market cap
- 523.50M
- P/E (TTM)i
- -5.13
- P/Bi
- 1.99
- EPSi
- -2.27
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on OCS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 46.00%
- Institutions
- 74
- As of
- 2026/Q3 vs. prior period
Holder types
VC/PE Fund21.49%
Hedge Fund10.96%
Mutual Fund8.77%
Corporate Pension Plan3.94%
Individual/Insider3.85%
Public Company0.51%
Private Company0.30%
Other50.15%
Top holders as of 2026-06-30
Eqt Fund Management S.à R.L.
11.26% · 6.95M sh
BVCF Management Ltd
3.95% · 2.44M sh
Gildi - lífeyrissjódur
3.94% · 2.43M sh
abrdn plc
3.50% · 2.16M sh
Millennium Management LLC
3.31% · 2.04M sh
Pivotal BioVenture Partners LLC
2.93% · 1.81M sh
Riad Sherif
2.11% · 1.30M sh
Citadel Advisors LLC
1.60% · 987.20K sh
Braidwell LP
1.35% · 834.18K sh
Perceptive Advisors LLC
1.31% · 808.83K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
1 filings tracked · 0 buys · 1 sells
| Name | Role | Stake |
|---|---|---|
| Christina Ackermann | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2025-10-08 | Christina Ackermann | Independent Director | Intent to Sell (Form 144) | -7,460 | $19.87 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:34:34 · For reference only, not investment advice and not tailored to your situation.